{"id":321156,"date":"2026-10-21T16:09:04","date_gmt":"2026-10-21T10:39:04","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=321156"},"modified":"2026-10-21T16:09:04","modified_gmt":"2026-10-21T10:39:04","slug":"tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/","title":{"rendered":"3 Tertiary Care Campus, Heart Care Network and Diagnostic Labs Stocks With a Strong Future Roadmap: Global Health, Narayana Hrudayalaya and Metropolis Healthcare"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Global Health, Narayana Hrudayalaya and Metropolis Healthcare: ROE of 12.6% to 17.8% and FY22 to FY26 revenue CAGR of 7.6% to 21.0%. Prices as of 20 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three healthcare delivery stocks to watch are Global Health, Narayana Hrudayalaya and Metropolis Healthcare. Their return on equity ranges from 12.6% to 17.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 21.0%. Narayana Hrudayalaya leads on both return on equity at 17.8% and revenue growth at 21.0% a year. Prices are based on the 20 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Healthcare delivery stocks follow the organisations that treat patients and test samples every day. Global Health, Narayana Hrudayalaya and Metropolis Healthcare cover a tertiary-care hospital group, an affordable cardiac and multi-specialty network and a national pathology laboratory chain.<\/p>\n<p>This list covers three healthcare delivery stocks with complete current figures: Global Health, Narayana Hrudayalaya and Metropolis Healthcare. Every figure comes from the latest reported financials and the 20 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#What_Are_Healthcare_Delivery_Stocks\" title=\"What Are Healthcare Delivery Stocks?\">What Are Healthcare Delivery Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Healthcare_Delivery_Stocks_at_a_Glance\" title=\"Healthcare Delivery Stocks at a Glance\">Healthcare Delivery Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Why_Do_Healthcare_Delivery_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Healthcare Delivery Stocks Have a Strong Roadmap in India?\">Why Do Healthcare Delivery Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Why_Global_Health_Features_Among_These_Healthcare_Delivery_Stocks\" title=\"Why Global Health Features Among These Healthcare Delivery Stocks\">Why Global Health Features Among These Healthcare Delivery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Why_Narayana_Hrudayalaya_Features_Among_These_Healthcare_Delivery_Stocks\" title=\"Why Narayana Hrudayalaya Features Among These Healthcare Delivery Stocks\">Why Narayana Hrudayalaya Features Among These Healthcare Delivery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Why_Metropolis_Healthcare_Features_Among_These_Healthcare_Delivery_Stocks\" title=\"Why Metropolis Healthcare Features Among These Healthcare Delivery Stocks\">Why Metropolis Healthcare Features Among These Healthcare Delivery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Global_Health_vs_Narayana_Hrudayalaya_vs_Metropolis_Healthcare_on_Key_Financials\" title=\"Global Health vs Narayana Hrudayalaya vs Metropolis Healthcare on Key Financials\">Global Health vs Narayana Hrudayalaya vs Metropolis Healthcare on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Key_Risks_to_Check_Before_Investing_in_Healthcare_Delivery_Stocks\" title=\"Key Risks to Check Before Investing in Healthcare Delivery Stocks\">Key Risks to Check Before Investing in Healthcare Delivery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Final_Thoughts_on_Healthcare_Delivery_Stocks\" title=\"Final Thoughts on Healthcare Delivery Stocks\">Final Thoughts on Healthcare Delivery Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#What_are_healthcare_delivery_stocks\" title=\"What are healthcare delivery stocks?\">What are healthcare delivery stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Which_healthcare_delivery_stocks_are_covered_in_this_list\" title=\"Which healthcare delivery stocks are covered in this list?\">Which healthcare delivery stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Why_do_healthcare_delivery_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do healthcare delivery stocks have a strong future roadmap in India?\">Why do healthcare delivery stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#How_has_Global_Health_performed_financially\" title=\"How has Global Health performed financially?\">How has Global Health performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#How_has_Narayana_Hrudayalaya_performed_financially\" title=\"How has Narayana Hrudayalaya performed financially?\">How has Narayana Hrudayalaya performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#How_has_Metropolis_Healthcare_performed_financially\" title=\"How has Metropolis Healthcare performed financially?\">How has Metropolis Healthcare performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#What_risks_should_investors_check_before_buying_healthcare_delivery_stocks\" title=\"What risks should investors check before buying healthcare delivery stocks?\">What risks should investors check before buying healthcare delivery stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-roadmap-waypoint-list\/#Is_this_list_of_healthcare_delivery_stocks_investment_advice\" title=\"Is this list of healthcare delivery stocks investment advice?\">Is this list of healthcare delivery stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Healthcare_Delivery_Stocks\"><\/span><strong>What Are Healthcare Delivery Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Healthcare delivery stocks are listed companies that run hospitals, clinics and laboratories. Their results depend on bed capacity, occupancy, the mix of procedures and the number of tests handled.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Healthcare_Delivery_Stocks_at_a_Glance\"><\/span><strong>Healthcare Delivery Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/medanta\/global-health-ltd-share-price-today\">Global Health<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,238.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33,277<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">60.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/nh\/narayana-hrudayalaya-ltd-share-price-today\">Narayana Hrudayalaya<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,740.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35,603<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">43.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.29<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/metropolis\/metropolis-healthcare-ltd-share-price-today\">Metropolis Healthcare<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">519.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10,780<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">53.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.15<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Narayana Hrudayalaya and Metropolis Healthcare trade at a P\/E below the industry P\/E, while Global Health trades above it, which reflects the growth the market already expects. Readers comparing healthcare delivery stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Healthcare_Delivery_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Healthcare Delivery Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Healthcare delivery stocks have a strong roadmap in India because demand for quality treatment and testing is growing faster than the number of organised beds and laboratories.<\/p>\n<ul>\n<li><strong>Insurance cover.<\/strong> More insured families choose organised hospitals and labs.<\/li>\n<li><strong>New capacity.<\/strong> Added beds and collection centres in proven cities lift volumes.<\/li>\n<li><strong>Complex care.<\/strong> Cardiac, cancer and transplant care draws patients to specialist centres.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Global_Health_Features_Among_These_Healthcare_Delivery_Stocks\"><\/span><strong>Why Global Health Features Among These Healthcare Delivery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the healthcare delivery stocks on this list, Global Health, which operates the Medanta brand, runs tertiary-care hospitals led by its flagship campus in Gurugram, along with facilities in Lucknow, Patna, Ranchi, Indore and Noida.<\/p>\n<p>In the June 2026 quarter, revenue grew 26.1% year on year to Rs 1,326 crore. Revenue rose from Rs 2,206 crore in FY22 to Rs 4,509 crore in FY26, a compound annual growth rate of 19.6%.<\/p>\n<p>Net profit grew from Rs 196 crore in FY22 to Rs 554 crore in FY26, which works out to a compound annual growth rate of 29.6%. The company has a return on equity of 14.1%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 33,277 crore. The stock trades at a P\/E of 60.3, above the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> Management is widening its reach in Tier 2 cities while adding capacity at the Gurugram campus. A broader doctor base and a rising share of complex procedures such as cardiac and transplant care support the earnings mix as new facilities mature.<\/p>\n<p><strong>What to watch:<\/strong> Watch the ramp-up speed of newer hospitals and the pace of doctor additions at each site.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Narayana_Hrudayalaya_Features_Among_These_Healthcare_Delivery_Stocks\"><\/span><strong>Why Narayana Hrudayalaya Features Among These Healthcare Delivery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the hospital and laboratory shares on this list, Narayana Hrudayalaya, widely known as Narayana Health, is a Bengaluru-based hospital group built around affordable cardiac care that now covers multiple specialities across India and also operates in the Cayman Islands.<\/p>\n<p>The company has a return on equity of 17.8%, a debt to equity ratio of 1.29 and a market capitalisation of Rs 35,603 crore. The stock trades at a P\/E of 43.6, below the industry P\/E of 59.6.<\/p>\n<p>Revenue rose from Rs 3,736 crore in FY22 to Rs 7,996 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 342 crore in FY22 to Rs 810 crore in FY26, which works out to a compound annual growth rate of 24.1%.<\/p>\n<p><strong>Roadmap:<\/strong> Growth is coming from bed additions across its hospital clusters, a rising share of higher-value specialities and an expanding insurance-led patient base. The group has a track record of running hospitals at high efficiency, which supports margins as scale builds.<\/p>\n<p><strong>What to watch:<\/strong> Keep an eye on occupancy in newly added beds and the payor mix between insurance and cash patients.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Metropolis_Healthcare_Features_Among_These_Healthcare_Delivery_Stocks\"><\/span><strong>Why Metropolis Healthcare Features Among These Healthcare Delivery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Metropolis Healthcare, headquartered in Mumbai, is a pathology and diagnostics company that runs a national network of laboratories, patient service centres and collection points, and also serves hospitals and corporate clients.<\/p>\n<p>Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%.<\/p>\n<p>In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 10,780 crore. The stock trades at a P\/E of 53.1, below the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> The company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.<\/p>\n<p><strong>What to watch:<\/strong> Follow test volumes per patient and the pace at which newer regions turn profitable.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Global_Health_vs_Narayana_Hrudayalaya_vs_Metropolis_Healthcare_on_Key_Financials\"><\/span><strong>Global Health vs Narayana Hrudayalaya vs Metropolis Healthcare on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three healthcare delivery stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Global Health<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,206<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,509<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">554<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Narayana Hrudayalaya<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,736<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,996<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">810<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Metropolis Healthcare<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,246<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,671<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">191<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.4%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Narayana Hrudayalaya posts the highest return on equity in this group at 17.8%. Narayana Hrudayalaya combines the largest FY26 revenue at Rs 7,996 crore with the fastest revenue growth, a 21.0% compound annual rate. A useful habit with healthcare delivery stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Healthcare_Delivery_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Healthcare Delivery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these healthcare delivery stocks, the main points are:<\/p>\n<ul>\n<li><strong>Ramp-up timing.<\/strong> New hospitals take time to reach stable occupancy.<\/li>\n<li><strong>Doctor availability.<\/strong> Expert doctors are central to growth and hard to attract.<\/li>\n<li><strong>Pricing rules.<\/strong> Changes in tariffs or price limits can affect revenue per patient.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter healthcare delivery stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Healthcare_Delivery_Stocks\"><\/span><strong>Final Thoughts on Healthcare Delivery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Healthcare delivery stocks suit investors who follow bed additions, occupancy and test volumes. Global Health, Narayana Hrudayalaya and Metropolis Healthcare each have a visible expansion path. Based on the 20 October 2026 close, Global Health trades at Rs 1,238.1, Narayana Hrudayalaya at Rs 1,740.9 and Metropolis Healthcare at Rs 519.1.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track healthcare delivery stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_healthcare_delivery_stocks\"><\/span><strong>What are healthcare delivery stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Healthcare delivery stocks are listed companies that run hospitals, clinics and laboratories. Their results depend on bed capacity, occupancy, the mix of procedures and the number of tests handled. This list looks at three of them, Global Health, Narayana Hrudayalaya and Metropolis Healthcare, using reported FY22 to FY26 financials and the 20 October 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_healthcare_delivery_stocks_are_covered_in_this_list\"><\/span><strong>Which healthcare delivery stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Global Health, Narayana Hrudayalaya and Metropolis Healthcare. Based on the 20 October 2026 close, Global Health traded at Rs 1,238.1, Narayana Hrudayalaya at Rs 1,740.9 and Metropolis Healthcare at Rs 519.1. Their return on equity ranges from 12.6% to 17.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 21.0%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_healthcare_delivery_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do healthcare delivery stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Healthcare delivery stocks have a strong roadmap in India because demand for quality treatment and testing is growing faster than the number of organised beds and laboratories. The main drivers are as follows. Insurance cover. More insured families choose organised hospitals and labs. New capacity. Added beds and collection centres in proven cities lift volumes. Complex care. Cardiac, cancer and transplant care draws patients to specialist centres. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Global_Health_performed_financially\"><\/span><strong>How has Global Health performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 2,206 crore in FY22 to Rs 4,509 crore in FY26, a compound annual growth rate of 19.6%. Net profit grew from Rs 196 crore in FY22 to Rs 554 crore in FY26, which works out to a compound annual growth rate of 29.6%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 1,326 crore. The company has a return on equity of 14.1%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 33,277 crore. The stock trades at a P\/E of 60.3, above the industry P\/E of 59.6. Looking ahead, management is widening its reach in Tier 2 cities while adding capacity at the Gurugram campus. A broader doctor base and a rising share of complex procedures such as cardiac and transplant care support the earnings mix as new facilities mature.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Narayana_Hrudayalaya_performed_financially\"><\/span><strong>How has Narayana Hrudayalaya performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,736 crore in FY22 to Rs 7,996 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 342 crore in FY22 to Rs 810 crore in FY26, which works out to a compound annual growth rate of 24.1%. The company has a return on equity of 17.8%, a debt to equity ratio of 1.29 and a market capitalisation of Rs 35,603 crore. The stock trades at a P\/E of 43.6, below the industry P\/E of 59.6. Looking ahead, growth is coming from bed additions across its hospital clusters, a rising share of higher-value specialities and an expanding insurance-led patient base. The group has a track record of running hospitals at high efficiency, which supports margins as scale builds.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Metropolis_Healthcare_performed_financially\"><\/span><strong>How has Metropolis Healthcare performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%. In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 10,780 crore. The stock trades at a P\/E of 53.1, below the industry P\/E of 59.6. Looking ahead, the company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_healthcare_delivery_stocks\"><\/span><strong>What risks should investors check before buying healthcare delivery stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying healthcare delivery stocks. Ramp-up timing. New hospitals take time to reach stable occupancy. Doctor availability. Expert doctors are central to growth and hard to attract. Pricing rules. Changes in tariffs or price limits can affect revenue per patient. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_healthcare_delivery_stocks_investment_advice\"><\/span><strong>Is this list of healthcare delivery stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 20 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are healthcare delivery stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Healthcare delivery stocks are listed companies that run hospitals, clinics and laboratories. Their results depend on bed capacity, occupancy, the mix of procedures and the number of tests handled. This list looks at three of them, Global Health, Narayana Hrudayalaya and Metropolis Healthcare, using reported FY22 to FY26 financials and the 20 October 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which healthcare delivery stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Global Health, Narayana Hrudayalaya and Metropolis Healthcare. Based on the 20 October 2026 close, Global Health traded at Rs 1,238.1, Narayana Hrudayalaya at Rs 1,740.9 and Metropolis Healthcare at Rs 519.1. Their return on equity ranges from 12.6% to 17.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 21.0%.\"}},{\"@type\":\"Question\",\"name\":\"Why do healthcare delivery stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Healthcare delivery stocks have a strong roadmap in India because demand for quality treatment and testing is growing faster than the number of organised beds and laboratories. The main drivers are as follows. Insurance cover. More insured families choose organised hospitals and labs. New capacity. Added beds and collection centres in proven cities lift volumes. Complex care. Cardiac, cancer and transplant care draws patients to specialist centres. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Global Health performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 2,206 crore in FY22 to Rs 4,509 crore in FY26, a compound annual growth rate of 19.6%. Net profit grew from Rs 196 crore in FY22 to Rs 554 crore in FY26, which works out to a compound annual growth rate of 29.6%. In the June 2026 quarter, revenue grew 26.1% year on year to Rs 1,326 crore. The company has a return on equity of 14.1%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 33,277 crore. The stock trades at a P\/E of 60.3, above the industry P\/E of 59.6. Looking ahead, management is widening its reach in Tier 2 cities while adding capacity at the Gurugram campus. A broader doctor base and a rising share of complex procedures such as cardiac and transplant care support the earnings mix as new facilities mature.\"}},{\"@type\":\"Question\",\"name\":\"How has Narayana Hrudayalaya performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,736 crore in FY22 to Rs 7,996 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 342 crore in FY22 to Rs 810 crore in FY26, which works out to a compound annual growth rate of 24.1%. The company has a return on equity of 17.8%, a debt to equity ratio of 1.29 and a market capitalisation of Rs 35,603 crore. The stock trades at a P\/E of 43.6, below the industry P\/E of 59.6. Looking ahead, growth is coming from bed additions across its hospital clusters, a rising share of higher-value specialities and an expanding insurance-led patient base. The group has a track record of running hospitals at high efficiency, which supports margins as scale builds.\"}},{\"@type\":\"Question\",\"name\":\"How has Metropolis Healthcare performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,246 crore in FY22 to Rs 1,671 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 143 crore in FY23 to Rs 191 crore in FY26, which works out to a compound annual growth rate of 10.1%. In the June 2026 quarter, revenue grew 15.7% year on year to Rs 455 crore, while net profit rose 25.7% to Rs 56.9 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.15 and a market capitalisation of Rs 10,780 crore. The stock trades at a P\/E of 53.1, below the industry P\/E of 59.6. Looking ahead, the company is deepening its presence in existing regions while extending into new cities through collection points and partner labs. A larger share of specialised tests in oncology, genetics and wellness lifts revenue per patient and helps its mix.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying healthcare delivery stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying healthcare delivery stocks. Ramp-up timing. New hospitals take time to reach stable occupancy. Doctor availability. Expert doctors are central to growth and hard to attract. Pricing rules. Changes in tariffs or price limits can affect revenue per patient. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of healthcare delivery stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 20 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Healthcare Delivery Stocks with a strong future roadmap: Global Health, Narayana Hrudayalaya and Metropolis Healthcare. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.<\/p>\n","protected":false},"author":34,"featured_media":321155,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[3803,7544,14112,14113,7226,7040,14114],"class_list":["post-321156","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-stocks","tag-global-health","tag-healthcare-delivery-stocks","tag-hospital-and-laboratory-shares","tag-metropolis-healthcare","tag-narayana-hrudayalaya","tag-patient-care-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["321155"],"rank_math_title":["Healthcare Delivery Stocks With a Strong Roadmap"],"rank_math_description":["Compare 3 healthcare delivery stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 20 Oct 2026."],"rank_math_focus_keyword":["healthcare delivery stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-tertiary-care-campus-heart-care-network-and-diagnostic-labs-stocks-with-a.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/321156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=321156"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/321156\/revisions"}],"predecessor-version":[{"id":321157,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/321156\/revisions\/321157"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/321155"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=321156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=321156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=321156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}